1. Home
  2. TCGL vs IMA Comparison

TCGL vs IMA Comparison

Compare TCGL & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCGL
  • IMA
  • Stock Information
  • Founded
  • TCGL 2015
  • IMA 2019
  • Country
  • TCGL Singapore
  • IMA United States
  • Employees
  • TCGL N/A
  • IMA N/A
  • Industry
  • TCGL EDP Services
  • IMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TCGL Technology
  • IMA Health Care
  • Exchange
  • TCGL Nasdaq
  • IMA Nasdaq
  • Market Cap
  • TCGL 85.6M
  • IMA 92.2M
  • IPO Year
  • TCGL 2025
  • IMA N/A
  • Fundamental
  • Price
  • TCGL $4.62
  • IMA $7.40
  • Analyst Decision
  • TCGL
  • IMA
  • Analyst Count
  • TCGL 0
  • IMA 0
  • Target Price
  • TCGL N/A
  • IMA N/A
  • AVG Volume (30 Days)
  • TCGL 670.4K
  • IMA 73.8K
  • Earning Date
  • TCGL 11-16-2025
  • IMA 11-15-2025
  • Dividend Yield
  • TCGL N/A
  • IMA N/A
  • EPS Growth
  • TCGL N/A
  • IMA N/A
  • EPS
  • TCGL N/A
  • IMA N/A
  • Revenue
  • TCGL $2,274,647.00
  • IMA $4,300,000.00
  • Revenue This Year
  • TCGL N/A
  • IMA N/A
  • Revenue Next Year
  • TCGL N/A
  • IMA N/A
  • P/E Ratio
  • TCGL N/A
  • IMA N/A
  • Revenue Growth
  • TCGL 7.80
  • IMA N/A
  • 52 Week Low
  • TCGL $3.95
  • IMA $7.23
  • 52 Week High
  • TCGL $5.43
  • IMA $23.28
  • Technical
  • Relative Strength Index (RSI)
  • TCGL N/A
  • IMA N/A
  • Support Level
  • TCGL N/A
  • IMA N/A
  • Resistance Level
  • TCGL N/A
  • IMA N/A
  • Average True Range (ATR)
  • TCGL 0.00
  • IMA 0.00
  • MACD
  • TCGL 0.00
  • IMA 0.00
  • Stochastic Oscillator
  • TCGL 0.00
  • IMA 0.00

About TCGL TechCreate Group Ltd. Class A Ordinary Shares

TechCreate Group Ltd is a technology consultancy and advanced software solution provider offering a comprehensive range of payment, cybersecurity, and digital services and solutions. It serves large institutions, financial institutions and telecommunication companies, by providing them with payment, cybersecurity, and digital solutions such as, the development of RTE, RTP, API management and other services, such as cybersecurity defense, IT infrastructure, and cloud services. Its core business areas comprise: (1) the provision of professional services, (2) the sale of software licenses and maintenance licenses, and (3) the sale of hardware solutions.

About IMA ImageneBio Inc. Common Stock

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

Share on Social Networks: